“…However, Schittenheln & Eisler (1932) and Barnes & Bueno (1933), using Thiry-Vella fistulas in dogs, were able to show that thyroxine was absorbed from the closed intestinal loops. There is some evidence that the form in which thyroxine is administered has a bearing on its activity after oral administration, and Thompson, Thompson & Dickie (1933) found that thyroxine by this route was most active as the sodium salt and that it can be used successfully in the treatment of myxoedema (cf. also Hart & Maclagan, 1950).…”